Insider Trading History of Afting Ernst-gunter

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Afting Ernst-gunter since 2008. The trader's CIK number is 1234864. At the time of the last reporting, Afting Ernst-gunter was the Director of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA). Also see all insider trading activities at Enanta Pharmaceuticals Inc.

Note that in the past AFTING ERNST-GUNTER also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Sequenom Inc (SQNM) by Afting Ernst-gunter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 SQNM 8,800 $67,300 6,300 $103,868 60,000 $193,500

Yearly summary of insider trading at Sorrento Therapeutics, Inc. (SRNE) by Afting Ernst-gunter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 SRNE 360,000 $50,400 0 $0 0 $0

Yearly summary of insider trading at Enanta Pharmaceuticals Inc (ENTA) by Afting Ernst-gunter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 ENTA 0 $0 15,000 $557,460 0 $0


Insider trading activities at 3 companies by Afting Ernst-gunter:

1. Sequenom Inc (SQNM)

2. Sorrento Therapeutics, Inc. (SRNE)

3. Enanta Pharmaceuticals Inc (ENTA)

Table 1. Insider trading of Sequenom Inc (SQNM) by Afting Ernst-gunter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-12-16 SQNM Option Ex 60,000 3.23 193,500
2008-12-09 SQNM Sale 6,300 16.49 103,868
2008-05-02 SQNM Buy 4,000 7.72 30,868
2008-05-05 SQNM Buy 4,800 7.59 36,432

Table 2. Insider trading of Sorrento Therapeutics, Inc. (SRNE) by Afting Ernst-gunter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-12-21 SRNE Buy 360,000 .14 50,400

Table 3. Insider trading of Enanta Pharmaceuticals Inc (ENTA) by Afting Ernst-gunter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-11 ENTA Sale 15,000 37.16 557,460

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Afting Ernst-gunter (Director of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.